Webinar: 𝗥𝗮𝗿𝗲 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗗𝗿𝘂𝗴 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝘄𝗶𝘁𝗵 𝗡𝗲𝘄 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝗠𝗲𝘁𝗵𝗼𝗱𝗼𝗹𝗼𝗴𝗶𝗲𝘀 (𝗡𝗔𝗠𝘀) 𝗶𝗻 𝘁𝗵𝗲 𝗘𝗨

Rare diseases affect millions of people worldwide, yet therapeutic development remains extremely challenging due to limited patient populations, disease complexity, and the lack of predictive research models. This BioMed21 webinar explores how human-relevant NAMs—including advanced 𝘪𝘯 𝘷𝘪𝘵𝘳𝘰 systems, organoids, organ-on-chip technologies, and 𝘪𝘯 𝘴𝘪𝘭𝘪𝘤𝘰 models—can help transform rare disease modelling and accelerate drug discovery. 𝗦𝗽𝗲𝗮𝗸𝗲𝗿𝘀: 🔹 Francesca Pistollato (Humane World for Animals) 🔹 Kevin Achberger (University of Tübingen) 🔹 Francesco Pappalardo (Università di Catania and the Combine Group - In Silico BioMedicine) 🔹 Manoe Janssen (Radboudumc) 𝗧𝗼𝗽𝗶𝗰𝘀 𝗶𝗻𝗰𝗹𝘂𝗱𝗲: 🔹 European research policy needs and strategies to advance human-centric rare disease research 🔹 Modeling diseases using retinal organoids and retina-chip platforms 🔹 In silico modelling and computational methods for rare disease research and drug development 🔹 Opportunities and challenges for integrating NAMs into rare disease therapy development 📄 Learn more about this initiative: https://biomed21.org/wp-content/uploa...